| Justin Bottsford-miller, MD | |
|
801 N 29th St, Billings, MT 59101-0905 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Justin Bottsford-miller |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 18 Years |
| Location | 801 N 29th St, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598986200 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 33051 (Montana) | Secondary |
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 33051 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bozeman Health Deaconess Hospital | Bozeman, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bozeman Health Deaconess Hospital | 4688984164 | 233 |
| St Vincent Hospital-hospital Sisters-third Order Of St Francis | 5799694675 | 562 |
News Archive
Despite those velvet paintings of poker-playing dogs smoking pipes, cigars and cigarettes, our canine friends really don't use tobacco. But like many humans who have never smoked, dogs still get lung cancer.
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the FDA intended to grant its recently-submitted ocriplasmin BLA (Biological License Application) for Priority Review.
› Verified 7 days ago
| Entity Name | Bozeman Health Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619347390 PECOS PAC ID: 4688984164 Enrollment ID: O20151112002559 |
News Archive
Despite those velvet paintings of poker-playing dogs smoking pipes, cigars and cigarettes, our canine friends really don't use tobacco. But like many humans who have never smoked, dogs still get lung cancer.
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the FDA intended to grant its recently-submitted ocriplasmin BLA (Biological License Application) for Priority Review.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Bottsford-miller, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Justin Bottsford-miller, MD 801 N 29th St, Billings, MT 59101-0905 Ph: (406) 238-2500 |
News Archive
Despite those velvet paintings of poker-playing dogs smoking pipes, cigars and cigarettes, our canine friends really don't use tobacco. But like many humans who have never smoked, dogs still get lung cancer.
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the FDA intended to grant its recently-submitted ocriplasmin BLA (Biological License Application) for Priority Review.
› Verified 7 days ago
Elizabeth V Connor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-5000 | |
Daniel M Molloy, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N, Ste 245w, Billings, MT 59101 Phone: 406-238-6010 Fax: 406-238-6022 | |
James F Metherell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dana P. Damron, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Dana C. Edwards, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Alexis N Hokenstad, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Christa Lynn Boggis-delacruz, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1045 N 30th St, Billings, MT 59101 Phone: 406-238-2500 |